Siemens healthineers launches enhanced liver fibrosis (elf) test in the u.s.

Tarrytown, n.y.--(business wire)--the enhanced liver fibrosis (elf) test from siemens healthineers is now available in the united states, providing broad clinical access to the minimally invasive prognostic tool. currently, the elf test is exclusively available through collaborations with labcorp (nyse: lh) and quest diagnostics (nyse: dgx), providing access (with a physician's order) across the country. this is the first time the test is commercially available in the u.s., following de novo ma
DGX Ratings Summary
DGX Quant Ranking